Your browser doesn't support javascript.
loading
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
Jacobs, Tom G; Mumbiro, Vivian; Cassia, Uneisse; Zimba, Kevin; Nalwanga, Damalie; Ballesteros, Alvaro; Domínguez-Rodríguez, Sara; Tagarro, Alfredo; Madrid, Lola; Mutata, Constantine; Chitsamatanga, Moses; Bwakura-Dangarembizi, Mutsa; Passanduca, Alfeu; Buck, W Chris; Nduna, Bwendo; Chabala, Chishala; Najjingo, Elizabeth; Musiime, Victor; Moraleda, Cinta; Colbers, Angela; Mujuru, Hilda A; Rojo, Pablo; Burger, David M.
Affiliation
  • Jacobs TG; Department of Pharmacy, Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Cassia U; Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
  • Zimba K; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Nalwanga D; Department of Paediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Ballesteros A; Pediatric Unit for Research and Clinical Trials, Hospital 12 de Octubre Health Research Institute, Biomedical Foundation of Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Domínguez-Rodríguez S; Pediatric Unit for Research and Clinical Trials, Hospital 12 de Octubre Health Research Institute, Biomedical Foundation of Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Tagarro A; Pediatric Unit for Research and Clinical Trials, Hospital 12 de Octubre Health Research Institute, Biomedical Foundation of Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Madrid L; Pediatric Service, Infanta Sofia University Hospital, Servicio Madrileño de Salud, Madrid, Spain.
  • Mutata C; Universidad Europea de Madrid, Madrid, Spain.
  • Chitsamatanga M; Pediatric Unit for Research and Clinical Trials, Hospital 12 de Octubre Health Research Institute, Biomedical Foundation of Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Bwakura-Dangarembizi M; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Passanduca A; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Buck WC; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Nduna B; University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe.
  • Chabala C; Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
  • Najjingo E; Universidade Eduardo Mondlane Faculdade de Medicina, Maputo, Mozambique.
  • Musiime V; David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California, USA.
  • Moraleda C; Arthur Davidson Children's Hospital, Ndola, Zambia.
  • Colbers A; University Teaching Hospitals-Children's Hospital, Lusaka, Zambia.
  • Mujuru HA; School of Medicine, University of Zambia, Lusaka, Zambia.
  • Rojo P; HerpeZ, Lusaka, Zambia.
  • Burger DM; Mbarara Regional Referral Hospital, Mbarara, Uganda.
Clin Infect Dis ; 78(3): 702-710, 2024 03 20.
Article in En | MEDLINE | ID: mdl-37882611
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / HIV Infections / Heterocyclic Compounds, 3-Ring Limits: Female / Humans / Infant / Male Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Rifampin / HIV Infections / Heterocyclic Compounds, 3-Ring Limits: Female / Humans / Infant / Male Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2024 Type: Article Affiliation country: Netherlands